Palo Alto Investors’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-4,915,931
Closed -$169M 51
2014
Q4
$169M Buy
4,915,931
+61,300
+1% +$2M 9.92% 2
2014
Q3
$145M Hold
4,854,631
10.83% 2
2014
Q2
$97.4M Buy
4,854,631
+12,600
+0.3% +$289K 7.25% 5
2014
Q1
$132M Sell
4,842,031
-41,848
-0.9% -$1.11M 10.88% 2
2013
Q4
$101M Buy
4,883,879
+320,359
+7% +$6.04M 9.44% 3
2013
Q3
$83.1M Buy
4,563,520
+1,715,678
+60% +$31M 8.7% 4
2013
Q2
$47.4M Buy
+2,847,842
New +$45.5M 5.59% 6

Other funds holding AUXL

Palo Alto Investors's AUXL Position: Q1 2015 in Review

Palo Alto Investors sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 4,915,931 shares — an estimated $169M sold.

Palo Alto Investors first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $169M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Palo Alto Investors reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Palo Alto Investors sold 4,915,931 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $169M.
  • Palo Alto Investors first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Palo Alto Investors's AUXILIUM PHARAMCEUTICALS INC position peaked at $169M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Palo Alto Investors's 13F filing for Q1 2015, filed 15 May 2015.